0% found this document useful (0 votes)
267 views

Management of DKA Presentation

This document provides an overview of diabetic ketoacidosis (DKA), including its history, epidemiology, pathophysiology, clinical presentation, diagnosis, treatment, monitoring, resolution, complications, and sick day management. DKA is a life-threatening complication of diabetes that results from absolute insulin deficiency and the metabolic alterations that follow. Key goals in treatment are improving circulation, reducing blood glucose and osmolality, clearing ketones from the blood and urine, correcting electrolyte imbalances, and identifying precipitating factors. Treatment involves intravenous fluids, insulin administration, and electrolyte replacement to resolve the condition.

Uploaded by

Muhammed Yesuf
Copyright
© Attribution Non-Commercial (BY-NC)
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PPTX, PDF, TXT or read online on Scribd
0% found this document useful (0 votes)
267 views

Management of DKA Presentation

This document provides an overview of diabetic ketoacidosis (DKA), including its history, epidemiology, pathophysiology, clinical presentation, diagnosis, treatment, monitoring, resolution, complications, and sick day management. DKA is a life-threatening complication of diabetes that results from absolute insulin deficiency and the metabolic alterations that follow. Key goals in treatment are improving circulation, reducing blood glucose and osmolality, clearing ketones from the blood and urine, correcting electrolyte imbalances, and identifying precipitating factors. Treatment involves intravenous fluids, insulin administration, and electrolyte replacement to resolve the condition.

Uploaded by

Muhammed Yesuf
Copyright
© Attribution Non-Commercial (BY-NC)
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PPTX, PDF, TXT or read online on Scribd
You are on page 1/ 46

MANAGEMENENT OF

DIABETIC KETO ACIDOSIS

MUHAMMED YESUF(M D)
University of Gondar
Presentation outline
Overview
History
Epidemiology
Pathophysiolgy
Clinical presentation
Dx and DDX
Rx
Monitoring
DKA Resolution
Complications
Sick day rule
Overview
One of the common and life threatening acute
complication of DM
Results from absolute insulin deficiency and its
resultant metabolic alterations
Accounts for 16% of DM related deaths
History
First full description
Jullius Dreschfeld 1886
Universally fatal till 1920’s
By 1930 MR 29%
By 1950 MR <10% invention of insulin
Cerebral edema in DKA
Dr’s from Philadelphia
Contributing universities-researches
University of Tennesse
Emory university
KPD 1987
Epidemiology
In type I
In young (<65)
More in women
MR <5% (1-2%)
Commonly from the precipitating factors
Pathophysiology
Insulin deficiency
Increased counter regulatory hormones (Glucagon,
cathecolamins, cortisol, GH)
Hyperglycemia
Impaired glucose utilization
 Decreased insulin - decreased GLUT 4
Increased glucose production
 Gluconogenesis
 Glyconogynolysis

Hyperglycemia
Draws water from cells Volume depletion
Induces glucosuria with osmotic diuresis
Volume depletion/ DHN depends on
Duration of hyperglycemia
Level of renal function
Pt fluid intake
Ketoacidosis
keton bodies from increase lipolysis
Decreased insulin

Lipolysis

Glycerol FFA
Maloyl CoA

Gluconogenesis TG, VLDL KB


Electrolyte disturbance
Na
balance of water shift from ICF to ECF Vs Osmotic
diuresis
hyperglycemia causes a sodium drop of 1meq of Na
for every 62mg/dl rise of glucose
corrected serum Na = measured Na + (∆SG(mg/dl) /42)
or
= measured Na + (∆SG (mmol/L) /2.3)
Generally loss of Na is 7-10 meq/kg
Normal Na level is equal to severe volume depletion
corrected serum Na > 140 meq/L – severe fluid
depletion
Renal failure – hyponatremia
K
Measured K can be high, low, normal. Generally there is
3-5 mg/Kg loss
urinary loss
GI loss
Loss from cells
Serum K is increase b/c of decreased insulin and
hyperosmolarity. Acidosis plays less role
Phosphate
Negative P balance
decreased intake
phoshaturia
Serum level can be normal or increased b/c of
decreased insulin
acidosis
Bicarbonate
Always low
Table : Total body deficits of water and electrolytes in DKA
DKA
Total water(l) 6
Water(ml/kg) 100
Na(meq/kg) 7-10
Cl(meq/kg) 3-5
K(meq/kg) 3-5
Po4(mmol/kg) 5-7
Mg(meq/kg) 1-2
Ca(meq/kg) 1-2
Clinical presentation
Sx
Early – poly Sx
Wt loss
Later – neurologic Sx (lethargy, focal signs, obtundation,
Coma)
Because of increased plasma osmolality. It occurs
when the effective plasma osmolality is 320 – 330. And it
can be calculated as
Effective Posm= [2*Na (meq/L)] + [glucose (mg/dl)/18]
Or
= [2*Na (mmol/L)] + [glucose (mmol/L)]

Effective Posm= [measured Posm]-[BUN (mg/dl) /2.8]


Or
= [measured Posm]-[BUN (mmol/L)]
Abdominal pain, nausea and vomiting
Abd pain associated with the degree of acidosis and could
be due to delayed gastric emptying or illus
Symptoms of precipitating factors
TABLE
Factors Most Often Associated with the Development of Diabetic Ketoacidosis
Factor
Approximate frequency (%)
Infection
35
Omission of insulin or inadequate insulin
30
Initial presentation of diabetes mellitus
20
Medical illness
10
Unknown
5
Signs
Signs of volume depletion
 Tachycardia, hypotension
 Dry mucusmembrane, reduced skin turgor

Tachypnea, kussmauls respiration


Acetone breath
Abdominal tendernes
Altered mental status
Lab abnormality
Serum glucose
 Elevated usually < 600 mg/dl. Could be >900mg/dl in
comatose pt. why?
 Could be normal – euglycemic DKA
 Starvation

 Pregnancy

 Liver disease

 Prior Rx with insulin


Serum electrolytes
 Na
K variable
P
 Bicarbonate-low

Not the total body amount reflected


BUN,Cr
 Could be elevated b/c of volume depletion
 Acetoacetate falsely elevates Cr

CBC
 Leucocytosis-b/c of increased cortisol and cathecolamines
 Can indicate infection
U/A
 Urine ketone
 UTI
 Diabetic nephropathy

Plasma osmolality
 Calculated as described before
 Usu in DKA 300-320

Serum ketones
 Nitropruside isnot a good method
 False negative b/c B-OHB is not detected by nitroprusside

 False positive with drugs like captopril,pencillamine,mesna


ABG
ECG
PH and bicarbonate
 Bicarbonate<15 meq/l
 PH 6.8-7.3

Anion gap>12
Additional lab studies
 Urine culture
 Sputum culture

 Blood culture

 CXR

 A1C

 Amylase lipase
DDX
Alcoholic ketoacidosis
Starvation ketosis
Anion gap acidosises
such as
 Lactic acidosis
 Salicylate intoxication

 Methanol/ethylene glycol intoxication

 Rhabdomyolysis
Table :Diagnostic criteria for DKA and classifications
parameters Mild Moderate Severe
Plasma glucose(mg/dl) >250 >250 >250
Arterial PH 7.25-7.30 7.00-7.24 <7.00
Serum bicarbonate(meq/l) 15-18 10-15 <10
Urine ketone positive positive positive
Serum ketone positive positive positive
Effective serum osm variable variable variable
Anion gap >10 >12 >12
Mentation alert Alert/drowsy Stupor/coma
TREATMENT
Initial evaluation
ABC
Mentation
altered-NG Tube
Volume status
Precipitating factors
May need emergency Rx
Goals of Rx
Improving circulatory volume and tissue perfusion
Reducing blood glucose and serum osmolality to normal
level
Clearing ketone from serum and urine at a steady state
Correcting the electrolyte imbalance
Identifying precipitating factors
Components of Rx
Fluid
Insulin
electrolytes
FLUID MX
It will
Increase intra vascular volume
Decrease BG (30-70mg/l) trough increase insulin
 Hemodilution sensitivity
 Urinary loss

Decrease counter regulatory hormones


The fluid deficit should be corrected over 24hrs
Rate depends on Pt volume status
Generally 10-15ml/Kg NS
Roughly the fluid can be given like this
1L-30 min
1L-2hrs
1L-4hrs
1L-6hrs
Then 1L every 6 hrs
Type of fluid depends on
Glucose level
Osmolality
Electrolyte composition
So initially NS then ½ NS
when BG<200-250mg/dl D5
When 1/2NS?
Why Dextrose?
NS Vs RL?
Fluid initially then insulin Vs simultaneous??????
INSULIN
Multiple dosing styles
1. 0.1u/kg bolus followed by 0.1u/kg continuous infusion
2. 0.14u/kg continuous infusion
3. S C administration –for mild DKA
0.3u/kg followed by 0.1u/kg till BG<250 mg/dl
then 0.05-0.1u/kg q1-2hr till resolution after that the
hrly admn will be stopped to change it to the standing
dose
This has shown equal efficacy with reduced
cost(39%)
4.??our protocol
0.3u/kg 1/2iv 1/2im/sc
Then 0.1u/kg im/sc q hr till BG is <250mg/dl
Then 0.05u/kg q hr till resolution
If no drop as expected(50-70mg/dl)
10iu iv bolus q hr
5. Im insulin
initially 20iu im then 5iu im q hr
if BG<250mg/dl-sc
After resolution
Naive Pts 0.5-0.8u/kg calculated to be given as
combination with 2/3 M and 1/3E
Known diabetics put on the previous dose
NB :regular insulin and the standing should overlap for
1-2 hr
Sliding scale
BG q 4 hr and for every 50mg/dl increase above
150mg/dl increase the insulin by 5iu up to a maximum of
20iu
For pts not feeding,in stressful condition
Standing dose with correction???
ELECTROLYTES
Potassium
<3.3meq/l
 Avoid insulin
 40-60meq of kcl /l

3.3-5.3meq/l
 Give insulin
 20-30meq of kcl /l

>5.3meq/l
 Give insulin
 No k

So k replacement is when serum k is <5.3 and with adequate urine out put
Better be replaced as 2/3 potassium chloride and 1/3 as potassium
phosphate b/c-it prevents hyperchloremic acidosis
-it provides phosphate
Bicarbonate
Not routine
Indications
 PH<7.0

 Life threatening hyperkalemia


Administration
PH <6.9 -100meq in 400ml sterile water with monitoring of
venous PH q 2hr till PH>7.0
Fear
 Neurologic deterioration

 Slow recovery from ketosis

 Post Rx metabolic alkalosis


Phosphorous
Not routine
Indications
 Cardiac dysfunction
 Hemolytic anemia
 Resp depression
 Serum level<1.0meq/l

Administration
 20-30meq of potassium phosphate
MONITORING
We can prepare pt data flow sheet w/h contains
Mental status
Vital sign
 T,PR,RR and depth, BP
Chemistries
 Serum glucose
 Urine ketone

 Serum e

 Serum BUN

 Effective serum osm

Insulin
 IV,IM,SC
Fluid
 NS/D5
UOP
Generally serum glucose q hr, chemistries q 2-4 hr with frequent clinical evaluation
DKA RESOLUTON
General improvement in sx
Pt able to feed
Normal anion gap <12meq/l
Serum glucose <200mg/dl
Serum bicarbonate>18meq/l
Venous PH>7.3
COMPLICATIONS
Hypokalemia
Hypoglycemia
ARDS
Cerebral edema
MI
DVT
Acute gastric dilatation
Erosive gastritis
Resp distress
Hypophospatemia
Infection……
Cerebral edema
Dxic criteria(murei etal)
 Abnormal response to pain
 Decorticate,decerebrate posturing
 CN palsy
 Abnormal resp pattern
 Fluctuating LOC
 Sustained bradycardya
 Incontinence
 More non specific-vomiting, headache, lethargy, elevated DBP
RX of cerebral oedema
 Mannitol 0.5-1gm/kg over 15-30 min, if no response repeat
after 20-30 min
 3%Saline 5-10mg/kg over 30min
 Hyper ventilation
 Surgical
Special considerations
pregnancy
 fetal mortality as high as 30% and increased to 60% when the
DKA is associated with coma
Children
 be alert to headache and reduced LOC
SICK DAY RULE
Golden rule –Never stop taking your insulin,b/c when
you are sick the body sugar increases
Foods and drinks-take non sugary fluids, continue
eating
Blood glucose and urinary ketone –q2-4hr
Insulin mx
BG>7mmol/l-increase the usual insulin by 10%
UK +ve-increase insulin by 20% of the daily dose
Calculate and take a correction insulin dose
could be repeated q2-4hr
THE END
??????????

You might also like